Clinical and Radiographic Evaluation of Laser Photobiomodulation Pulpotomy of Primary Molars in Children

Aliaa Hamouda

Status

Enrolling

Conditions

Pulpitis

Pulpotomy

Treatments

Device: Photobiomodulation

Drug: MTA

Study type

Interventional

Funder types

Other

Identifiers

NCT05850780

#12

Details and patient eligibility

About

This study aimed to evaluate the clinical and radiographic outcomes of photobiomodulation pulpotomy compared to MTA pulpotomy in primary molars in children.

Enrollment

52 estimated patients

Sex

All

Ages

5 to 7 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Children with dental behavior score of 3 or 4 according to the Frankel behavior rating scale.
Patients whom their maxillary primary molars are indicated for pulpotomy and SSC restoration.
Lack of history of allergy to the materials used for anesthesia and sulfite.
Children free of any systemic disease or special health care needs (ASA 1).
Completion of the written informed consent form by parents/guardian.

Exclusion criteria

Children who receive any analgesic drugs at least 24 hours before treatment.
Any inflammation or lesion in the injection site
Patients who have previous bad experience of dentistry were excluded to eliminate the possible impact of the child's previous painful or stressful experiences
Child coming for emergency treatment of pain.
If hemostasis is not achieved within five minutes after application of moist cotton pellet directly to the pulp stumps
If radicular pulp tissue was not vital due to the presence of suppuration or purulent necrosis (pus discharge).